FTI CONSULTING, INC FCN

Industrials SIC 8742 - Services-Management Consulting Services NYSE

Unless otherwise indicated or required by the context, when we use the terms "Company," "FTI Consulting," "we," "us" and "our," we mean FTI Consulting, Inc., a Maryland corporation, and its consolidated subsidiaries.

FTI Consulting is a leading global expert firm for organizations facing crisis and transformation. Individually, each of our segments and practices is staffed with experts recognized for the depth of their knowledge and a track record of making an impact.

•Strategic Communications.

The Company renamed its Corporate Finance & Restructuring segment to Corporate Finance to better align with the segment's business activities, structure and strategy, as of December 31, 2025. The segment name change did not result in any change to the composition of the segment and has no impact on previously reported financial information.

Last close 151.70 2026-09-04
Market cap $4.19B 2026-06-30 share count
52-week range 137.65 - 189.30

Valuation FY2025 figures against the last close

P/S1.1x
P/E18.4x
P/FCF44.8x
EV/EBITDA9.9x
Dividend yield
Diluted EPS8.24

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $3.79B$3.70B$3.49B$3.03B$2.78B$2.46B$2.35B$2.03B$1.81B$1.81B
Cost of revenue $2.57B$2.52B$2.35B$2.07B$1.92B$1.67B$1.53B$1.33B$1.22B$1.21B
Gross profit $1.22B$1.18B$1.14B$962.9M$860.7M$788.6M$817.8M$699.8M$592.2M$599.6M
SG&A $799.6M$822.2M$751.3M$641.1M$537.8M$488.4M$504.1M$465.6M$432.0M$436.7M
Total operating expenses $3.40B$3.35B$3.11B$2.73B$2.46B$2.18B$2.05B$1.80B$1.70B$1.67B
Operating income $389.1M$347.4M$377.6M$303.9M$312.0M$282.7M$305.6M$226.0M$108.7M$142.2M
Interest expense $21.4M$7.0M$14.3M$10.0M$20.3M$19.8M$19.2M$27.1M$25.4M$24.8M
Pre-tax income $371.0M$350.8M$358.4M$297.7M$297.9M$262.4M$288.4M$207.8M$87.1M$127.8M
Income tax $100.1M$70.7M$83.5M$62.2M$63.0M$51.8M$71.7M$57.2M$20.9M$42.3M
Net income $270.9M$280.1M$274.9M$235.5M$235.0M$210.7M$216.7M$150.6M$108.0M$85.5M
EPS, basic 8.337.968.106.997.025.925.894.062.792.09
EPS, diluted 8.247.817.716.586.655.675.693.932.752.05
Shares, diluted (wtd. avg.) $32.9M$35.8M$35.6M$35.8M$35.3M$37.1M$38.1M$38.3M$39.2M$41.7M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $265.1M$660.5M$303.2M$491.7M$494.5M$295.0M$369.4M$312.1M$190.0M$216.2M
Short-term investments $0$25.5M$0
Receivables $1.04B$1.02B$1.10B$896.2M$754.1M$711.4M$693.4M$554.6M$522.9M$474.9M
Total current assets $1.52B$1.82B$1.56B$1.51B$1.37B$1.13B$1.18B$965.4M$794.2M$783.2M
Property, plant and equipment $169.3M$150.3M$159.7M$153.5M$142.2M$101.6M$93.7M$84.6M$75.1M$61.9M
Goodwill $1.24B$1.23B$1.23B$1.23B$1.23B$1.23B$1.20B$1.17B$1.20B$1.18B
Other intangibles $13.5M$16.8M$18.3M$25.5M$32.0M$41.5M$38.4M$34.6M$44.1M$52.1M
Total assets $3.49B$3.60B$3.33B$3.24B$3.10B$2.78B$2.78B$2.38B$2.26B$2.23B
Accounts payable $15.0M$26.0M$21.7M$20.3M$16.2M$13.1M$18.3M$17.7M$14.1M$15.8M
Short-term debt $0$0$0$0$0$0$0$0
Total current liabilities $975.2M$931.8M$892.8M$769.5M$718.1M$670.2M$612.5M$482.6M$410.3M$378.5M
Long-term debt $365.0M$0$0$315.2M$297.2M$286.1M$275.6M$265.6M$396.3M$365.5M
Total liabilities $1.76B$1.34B$1.34B$1.56B$1.52B$1.38B$1.29B$1.03B$1.07B$1.02B
Retained earnings $1.86B$2.39B$2.11B$1.86B$1.70B$1.51B$1.41B$1.20B$1.05B$941.0M
Total equity $1.73B$2.26B$1.98B$1.68B$1.58B$1.40B$1.49B$1.35B$1.19B$1.21B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $152.1M$395.1M$224.5M$188.8M$355.5M$327.1M$217.9M$230.7M$147.6M$233.5M
Depreciation and amortisation $45.8M$43.9M$41.1M$35.9M$34.3M$32.6M$30.1M$26.2M$24.4M$26.7M
Stock-based compensation $39.3M$38.4M$29.5M$25.4M$23.1M$22.9M$18.0M$15.6M$16.0M$16.9M
Capital expenditure $58.5M$35.4M$49.5M$53.3M$68.7M$34.8M$41.8M$32.3M$32.0M$28.9M
Investing cash flow -$58.5M-$10.2M-$73.8M-$60.1M-$79.1M-$60.1M-$60.6M$18.7M-$40.6M-$30.1M
Financing cash flow -$510.5M-$15.4M-$354.7M-$106.0M-$61.7M-$360.1M-$103.3M-$117.5M-$140.9M-$125.3M
Buybacks $858.7M$10.2M$21.0M$85.4M$46.1M$353.6M$105.8M$55.7M$168.1M$21.5M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-165147.

Others in SIC 8742

TickerCompanyMarket capP/ERevenue growth
BAH Booz Allen Hamilton Holding Corp $8.76B 10.6x -6.4%
G Genpact LTD $6.27B 11.9x 6.6%
EXPO EXPONENT INC $3.25B 33.0x 4.2%
HURN Huron Consulting Group Inc. $2.52B 26.6x 11.9%
ASTH Astrana Health, Inc. $2.14B 83.6x 56.4%
ICFI ICF International, Inc. $1.58B 17.8x -7.3%
BWMN Bowman Consulting Group Ltd. $735.5M 58.1x 14.9%
ONT Onterris, Inc. $626.8M 19.3%